IRAK4-IN-21 |
| Catalog No.GC69288 |
IRAK4-IN-21 (Compound 17) is an orally effective and selective potent IRAK4 inhibitor with IC50 values of 5 and 56 nM for IRAK4 and TAK1, respectively. It can effectively inhibit the production of IL-23 (IC50=0.17 μM) and may be used in research on autoimmune diseases such as psoriasis vulgaris and psoriatic arthritis.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2170694-04-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for IRAK4-IN-21
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for IRAK4-IN-21
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *